Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 9.06 is 39% above its 3-year average of 6.51, around the middle of its 3-year range (0.00–17.17).
As of the fiscal period ended Tuesday, June 30, 2026. 27.54% above its 12-month average of 7.10.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.06.
QUICK RATIO (ACID-TEST)
9.06
QUICK RATIO (ACID-TEST) AVG TTM
7.10
QUICK RATIO (ACID-TEST) AVG 3Y
9.16
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+27.54%
CURRENT VS 3Y AVG
-1.07%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 741 covered companies
CURRENT VS SECTOR MEDIAN
+183.95%
vs the sector median at left
Kyverna Therapeutics, Inc.
Market Cap
$384.40M
Quick Ratio (Acid-Test)
9.06
TTM Avg
7.10
3Y Avg
9.16
5Y Avg
N/A
Market Cap
$386.23M
Quick Ratio (Acid-Test)
1.67
TTM Avg
1.85
3Y Avg
1.69
5Y Avg
1.72
Market Cap
$378.17M
Quick Ratio (Acid-Test)
5.88
TTM Avg
5.65
3Y Avg
4.80
5Y Avg
5.41
Market Cap
$393.42M
Quick Ratio (Acid-Test)
2.86
TTM Avg
2.54
3Y Avg
2.71
5Y Avg
3.53
Market Cap
$393.86M
Quick Ratio (Acid-Test)
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
Market Cap
$373.86M
Quick Ratio (Acid-Test)
2.39
TTM Avg
2.24
3Y Avg
1.74
5Y Avg
3.80
Market Cap
$364.53M
Quick Ratio (Acid-Test)
12.19
TTM Avg
4.83
3Y Avg
10.20
5Y Avg
8.85
Market Cap
$408.59M
Quick Ratio (Acid-Test)
8.66
TTM Avg
7.11
3Y Avg
5.24
5Y Avg
5.24
Market Cap
$408.96M
Quick Ratio (Acid-Test)
8.92
TTM Avg
6.16
3Y Avg
7.06
5Y Avg
7.06
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | $384.40M | 9.06 | 7.10 | 9.16 | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $386.23M | 1.67 | 1.85 | 1.69 | 1.72 |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $378.17M | 5.88 | 5.65 | 4.80 | 5.41 |
| REGENXBIO Inc. (RGNX)vs › | $393.42M | 2.86 | 2.54 | 2.71 | 3.53 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $393.86M | 16.52 | 13.61 | 8.86 | 8.86 |
| Canopy Growth Corporation (CGC)vs › | $373.86M | 2.39 | 2.24 | 1.74 | 3.80 |
| Opus Genetics, Inc. (IRD)vs › | $364.53M | 12.19 | 4.83 | 10.20 | 8.85 |
| Carlsmed, Inc. (CARL)vs › | $408.59M | 8.66 | 7.11 | 5.24 | 5.24 |
| Shoulder Innovations, Inc. (SI)vs › | $408.96M | 8.92 | 6.16 | 7.06 | 7.06 |
| Ocugen, Inc. (OCGN)vs › | $359.46M | 0.80 | 1.96 | 2.47 | 5.28 |
Quick Ratio
9.06
Excludes inventory
Current Ratio
9.06
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 9.06 |
| 2026-03-31 | 8.15 |
| 2025-12-31 | 7.75 |
| 2025-09-30 | 5.16 |
| 2025-06-30 | 5.39 |
| 2025-03-31 | 7.44 |
| 2024-12-31 | 8.61 |
| 2024-09-30 | 10.50 |
| 2024-06-30 | 14.86 |
| 2024-03-31 | 17.17 |
| 2023-12-31 | 3.05 |
| 2023-09-30 | 4.71 |
| 2023-06-30 | 17.17 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
